Fig. 8.From: Anti-Epcam Aptamer (Syl3c)-Functionalized Liposome for Targeted Delivery Of Doxorubicin: In Vitro And In Vivo Antitumor Studies in Mice Bearing C26 Colon CarcinomaTissue biodistribution. The results of DOX biodistribution in heart, tumor, liver, lung spleen, and kidney. The concentrations (μg/g) reported at 3, 12, 24, 48, and 72 h post-injection for each organ. Data represented as mean ± standard deviation (SEM) (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001Back to article page